Sandoz AG, Basel (CH)
Osama joined Novartis as Global Head Business Development & Licensing (BD&L) and Mergers & Acquisitions (M&A) in 2021. In this role, he leads the worldwide strategy for BD&L and M&A for Sandoz Division with a focus on delivering value through defining and implementing the strategy specifically around co-development agreements, licensing, product acquisitions & divestment. He is part of the Business Office Leadership Team (BOLT) and BD&L/M&A Management Team. Osama’s expertise includes business development, licensing, strategy, and planning.
Osama has focused his education and career on business, health, and science with a view to transforming the marketing strategy developments and product planning experience. He has undertaken a Master of Business Administration, Bachelor of Science in Medical Laboratory Technology along with a Master of Science in Basic and Molecular Biology.
Osama has previously held a range of leadership roles including Vice President Business Development and Alliance Management at HIKMA Pharmaceuticals and Senior Director of Marketing Analytics and Business Insight for Abbott Laboratories (NYSE). Prior to this, he was Director of Business Analysis and Information at Amgen Inc.